Swiss dental implant maker Straumann (STMN.S) said it would axe roughly 150 jobs to boost margins as it grapples with sluggish demand in Europe, its biggest market. The euro zone debt crisis has battered sales of dental implants made by Straumann and its Swiss rival Nobel Biocare (NOBN.S) as cash-strapped Europeans, worried about the downturn, … Continue reading